Osh project, fighting TB
The prevalence of drug-resistant tuberculosis (DR-TB) in Kyrgyzstan, one of the poorest nations in the Central Asian region, remains very high.

Kyrgyzstan has an inadequate healthcare system, experiencing frequent shortages, and today, many people struggle to access free treatment for DR-TB.

The rates of drug resistance among new TB cases are as high as one third, and in previously treated TB cases, more than half of patients have developed the drug resistant form of the disease.

We provide outpatient care for people with DR-TB, thereby limiting the time they have to spend in hospital. Patients attend monthly medical consultations at one of three TB clinics supported by us, and include psychological support.

In April 2020, MSF teams started responding to the coronavirus COVID-19 pandemic in the country.

In 2019
 
COVID-19, Ayderkan
Kyrgyzstan

In remote Kyrgyzstan, COVID-19 puts a strain on the health system

Project Update 22 Jul 2020
 
Osh project, fighting TB
Tuberculosis

Video innovation helps TB patients comply with their treatment

Voices from the Field 22 Mar 2019
 
Osh project, fighting TB
Kyrgyzstan

Experts to tackle the deadly threat of TB in Eastern Europe and Central Asia Symposium

Press Release 1 Mar 2018
 
Tondo project in Philippines
Photo Story

A year in pictures 2017

18 Dec 2017
Photo Story
 
Photo Story
22 Mar 2013
Photo Story
 
Kyrgyzstan

Tension and violence continue in south Kyrgyzstan MSF calls for impartial access to health care

Press Release 20 Jul 2010